HOLLISTON, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its monetary outcomes for third quarter ended September 30, 2022 after the market closes on November 8, 2022, and can maintain a convention name to debate the outcomes at 4:30 p.m. Eastern Time.
Participants who wish to be part of the decision and ask a query should register right here. Once registered, you’ll obtain the dial-in numbers and a distinctive PIN quantity.
Participants who wish to be part of the audio-only webcast ought to go to our occasions and shows on the investor web site right here.
Financial data introduced on the decision, together with the earnings launch and a associated slide presentation, shall be accessible on the Investor Relations part of Harvard Bioscience’s web site.
About Harvard Bioscience
Harvard Bioscience is a number one developer, producer and vendor of applied sciences, services and products that allow basic analysis, discovery, and pre-clinical testing for drug growth. Our clients vary from famend tutorial establishments and authorities laboratories, to the world’s main pharmaceutical, biotechnology and contract analysis organizations. With operations in North America, Europe and China, we promote by means of a mixture of direct and distribution channels to clients world wide.
For extra data, please go to our web site at www.harvardbioscience.com.
Investor Contact
Michael Rossi
Chief Financial Officer
(508) 893-8999
[email protected]
